Fly News Breaks for February 27, 2020
Feb 27, 2020 | 08:41 EDT
Oppenheimer analyst Leland Gershell raised the firm's price target on BioMarin to $88 from $80 following estimate revisions made on the company's earnings update. The analyst keeps a Perform rating on the shares on higher price target.
News For BMRN From the Last 2 Days
There are no results for your query BMRN